Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study
- PMID: 19406983
- DOI: 10.1164/rccm.200808-1341OC
Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study
Abstract
Rationale: Obstructive sleep apnea (OSA) is an independent risk factor for stroke, but little is known about the role of continuous positive airway pressure (CPAP) on mortality in patients with stroke.
Objectives: To analyze the independent impact of long-term CPAP treatment on mortality in patients with ischemic stroke.
Methods: Prospective observational study in 166 patients with ischemic stroke. Sleep study was performed in all of them and CPAP treatment was offered in the case of moderate to severe cases. Patients were followed-up for 5 years to analyze the risk of mortality.
Measurements and main results: Of 223 patients consecutively admitted for stroke, a sleep study was performed on 166 of them (2 mo after the acute event). Thirty-one had an apnea-hypopnea index (AHI) of less than 10; 39 had an AHI between 10 and 19, and 96 had an AHI of 20 or greater. CPAP treatment was offered when AHI was 20 or greater. Patients were followed up in our outpatient clinic at 1, 3, and 6 months, and for every 6 months thereafter for 5 years (prospective observational study). Mortality data were recorded from our computer database and official death certificates. The mean age of subjects was 73.3 +/- 11 years (59% males), and the mean AHI was 26 (for all patients with a predominance of obstructive events). Patients with an AHI of 20 or greater who did not tolerate CPAP (n = 68) showed an increase adjusted risk of mortality (hazards ratio [HR], 2.69; 95% confidence interval [CI], 1.32-5.61) compared with patients with an AHI of less than 20 (n = 70), and an increased adjusted risk of mortality (HR, 1.58; 95% CI, 1.01-2.49; P = 0.04) compared with patients with moderate to severe OSA who tolerated CPAP (n = 28). There were no differences in mortality among patients without OSA, patients with mild disease, and patients who tolerated CPAP.
Conclusions: Our results suggest that long-term CPAP treatment in moderate to severe OSA and ischemic stroke is associated with a reduction in excess risk of mortality.
Similar articles
-
Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment.Eur Respir J. 2012 Apr;39(4):906-12. doi: 10.1183/09031936.00011311. Epub 2011 Sep 29. Eur Respir J. 2012. PMID: 21965227
-
Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study.Am J Respir Crit Care Med. 2012 Nov 1;186(9):909-16. doi: 10.1164/rccm.201203-0448OC. Epub 2012 Sep 13. Am J Respir Crit Care Med. 2012. PMID: 22983957
-
Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study.Ann Intern Med. 2012 Jan 17;156(2):115-22. doi: 10.7326/0003-4819-156-2-201201170-00006. Ann Intern Med. 2012. PMID: 22250142
-
Non-CPAP therapies in obstructive sleep apnoea: mandibular advancement device therapy.Eur Respir J. 2012 May;39(5):1241-7. doi: 10.1183/09031936.00144711. Epub 2011 Nov 10. Eur Respir J. 2012. PMID: 22075487 Review.
-
Treatment of sleep apnea in heart failure.Am J Respir Crit Care Med. 2006 Jun 15;173(12):1300-8. doi: 10.1164/rccm.200511-1745PP. Epub 2006 Mar 9. Am J Respir Crit Care Med. 2006. PMID: 16528015 Review.
Cited by
-
The mobile sleep medicine model in neurologic practice: Rationale and application.Front Neurol. 2022 Oct 28;13:1032463. doi: 10.3389/fneur.2022.1032463. eCollection 2022. Front Neurol. 2022. PMID: 36388176 Free PMC article. Review.
-
Continuous positive airway pressure and cardiovascular events in patients with obstructive sleep apnea.Curr Cardiol Rep. 2013 Aug;15(8):385. doi: 10.1007/s11886-013-0385-z. Curr Cardiol Rep. 2013. PMID: 23873341 Review.
-
SAS Care 1: sleep-disordered breathing in acute stroke an transient ischaemic attack - prevalence, evolution and association with functional outcome at 3 months, a prospective observational polysomnography study.ERJ Open Res. 2020 Jun 15;6(2):00334-2019. doi: 10.1183/23120541.00334-2019. eCollection 2020 Apr. ERJ Open Res. 2020. PMID: 32577418 Free PMC article.
-
Sleep for Stroke Management and Recovery Trial (Sleep SMART): Rationale and methods.Int J Stroke. 2020 Oct;15(8):923-929. doi: 10.1177/1747493020903979. Epub 2020 Feb 4. Int J Stroke. 2020. PMID: 32019428 Free PMC article. Clinical Trial.
-
Sleep apnea treatment after stroke (SATS) trial: is it feasible?J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1216-24. doi: 10.1016/j.jstrokecerebrovasdis.2011.06.010. Epub 2011 Jul 23. J Stroke Cerebrovasc Dis. 2013. PMID: 21784661 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical